Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Precision Cancer Software Startup BostonGene Lands $50M in Series A Round

Precision Cancer Software Startup BostonGene Lands $50M in Series A Round

Apr 25, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Biomedical software startup BostonGene today announced that it has received a $50 million Series A investment from Japanese software giant NEC.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Free of Influence

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

Avoiding the MARCH1 to 1-Mar Change

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

Nature Papers Reveal Tuatara Genome, Cell Populations Involved in Lupus

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

Overlooked Expertise

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.

What's Popular?

In Business News

  1. Rakuten Medical Sues Illumina Over Trademark Dispute

  2. Blackstone to Acquire Ancestry for $4.7B

  3. Luminex Responds to FDA Warning Letter While Ramping SARS-CoV-2 Test Manufacturing

    Premium

  4. Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business

  5. Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.